FluoSphera
Don't let the drug decide for you
Geneva, Switzerland · Founded 2021
- Headquarters
- Geneva
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- fluosphera.com
- Last Round
- SeedJan 2026
- Rounds
- 1
About
FluoSphera is a Swiss biotech company developing a human multi-tissue platform for next-generation drug discovery. Its technology uses encapsulated organ-like microtissues to mimic systemic clinical drug responses, enabling high-throughput, human-relevant in vitro drug profiling before clinical trials. The company is headquartered in Geneva, Switzerland, with a US presence in Boston.
Summary
FluoSphera is a Biotech company based in Geneva, Switzerland, founded in 2021. Its most recent funding was a Seed round in Jan 2026. Investors include Wake-Up Capital, Inovexus and Stamco AG.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company